A RAPS pre-approved webinar on the topic, "Developing and Maintaining Pre-marketing Master Regulatory Files" is being conductedon August 1 by GlobalCompliancePanel, a leading regulatory and compliance continuing education training provider.
The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has announced that the company is prepared for the increasing number of Advanced Therapy trials, a trend that is expected to continue for the next 10 to 15 years.
A RAPS pre-approved webinar on the topic, "Safety Critical Software -Software Risk Management" is being held by GlobalCompliancePanel, a leading regulatory and compliance continuing education training provider on October 4. This webinar earns 1.00 RAC credits towards a participant's RAC recertification upon full completion.
Copernicus Group IRB (CGIRB), a leading independent institutional review board, today announced the promotion of Dawn Pope to Chief Operating Officer. In her new position, Ms. Pope will provide leadership and direction for the overall operations of the company, planning and coordinating the development of strategic objectives and goals.
The Larvol Group, LLC, announced today that it will launch its pharmaceutical CI platform, Larvol DeltaTM at the upcoming Pharma CI Conference on September 11th and 12th in Parsippany, New Jersey.
AdvantaPure recently launched a redesigned website. The update offers improved navigation, a simplified appearance, and keyword and part number search capabilities. Featuring high purity tubing, single use system components, and hose identification solutions, the site presents products for the pharmaceutical, biopharmaceutical, biomedical, food, beverage, and cosmetic industries.
Factors such as a large population, rising incomes and expanding healthcare infrastructure are expected to allow more people in the emerging markets to afford western medication.
Novartis welcomed its annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 60 selected students from leading international universities in 21 countries and territories.
AdvantaPure will exhibit at several key pharmaceutical trade shows this fall. Events include the BioProcess International Conference and Exhibition, the ISPE Annual Meeting, and an exhibition first for the company, China Pharm.
Michael Nohaile, Global Head of Novartis Molecular Diagnostics, will give a featured presentation on 'The Biomarker is not the end - it's just the beginning' at GTC's 2nd Biomarker Europe Summit (Sept 5th-7th, 2012 in Zurich, Switzerland).
The 11th Annual Biological Production Forum 2012 is pleased to announce that the Director, Cell Culture Process Development at Shire will be presenting a case study.
Khusru Asadullah, Vice President and Head of Global Biomarkers at Bayer Pharma AG, will give a keynote presentation on 'Open Innovation for Biomarkers' at GTC's 2nd Biomarker Europe Summit (Sept 5th-7th, 2012 in Zurich, Switzerland).
Tony W. Ho, Vice President of Clinical New Opportunities iMED at AstraZeneca will give a featured presentation entitled "From Withdrawal to Connoisseur: Efficient Pathway to POC in Pain" at the Pain Research and Therapeutics Conference taking place on Sept 13-14, 2012 in San Francisco, CA.
Marcus Brewster, Vice President of Pharmaceutical Development & Manufacturing Sciences at Janssen R&D (a Johnson & Johnson company) will give the Keynote Presentation on "Improving Oral Bioavailability for Poorly Water-soluble Drug Candidates" at the Drug Delivery Technologies & Formulation Conference on Sep 5-6, 2012 in Zurich, Switzerland.
Jeffrey Ulmer, global head of external research at Novartis, will give a Featured Presentation on "Technologies for the Discovery and Development of New Vaccines" at the Drug Delivery Technologies & Formulation Conference to be held on Sep 5-6, 2012 in Zurich, Switzerland.
High purity processing components are critical in pharmaceutical, biopharmaceutical, and other clean applications. AdvantaPure's silicone and thermoplastic elastomer tubing has been extensively tested for extractables to prove the products' suitability for high purity uses. Complimentary summary and comprehensive reports are available from the company upon request.
Glythera, an emerging biopharmaceutical company specialising in protein/peptide functionalisation and glycosylation, has secured a fundraising round totalling £2M with IP Group, which will be tranched over the next three years.
Telormedix SA and Foamix Ltd., two clinical stage biopharmaceutical companies focused on TLR7 agonists in the treatment of cancer and inflammatory diseases and on topical foam delivery systems announced that they have raised funding to coordinate a two-year research project aimed at developing a new skin cancer topical treatment based on a foam formulation of one of the Company's drug candidates.
Satisfied Users & 
Approved Press Releases
